Accounts Payable, Accrued Expenses and Other

12 Months Ended

Dec. 31, 2017

10. Accounts Payable, Accrued Expenses and Other

Accounts payable, accrued expenses and other as of December 31, 2017 and 2016 consisted of the following:

	December 31,
(in thousands)	2017		2016
Accounts payable	$	2,887	$	2,692
Accrued goods and services		5,663		7,534
Accrued clinical trial costs		3,901		8,776
Accrued drug purchase costs		222		480
Accrued payroll and related benefits		2,884		3,394
Accrued restructuring expenses		628		774
Accrued interest		—		2,100
Accrued dividends payable		19		19
Silver Creek warrant liability		—		1,499
Deferred tax incentives		1,402		1,402
Total accounts payable, accrued expenses and other	$	17,606	$	28,670